Could a common steroid save lives in sepsis? new trial investigates
NCT ID NCT05136560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving the steroid dexamethasone early to people with severe sepsis is safe and helps them survive. It included 102 high-risk patients and measured deaths within 28 and 90 days. The goal was to see if this simple treatment could improve outcomes in a life-threatening condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bundang CHA hospital
Seongnam-si, Gyeonggi-do, 13488, South Korea
-
Samsung Hospital
Seoul, 06351, South Korea